Atıf Formatları
Gemcitabine and cisplatin in patients with carcinoma of unknown primary site
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

M. Isik Et Al. , "Gemcitabine and cisplatin in patients with carcinoma of unknown primary site," Medical Oncology , vol.28, no.2, pp.591-596, 2011

Isik, M. Et Al. 2011. Gemcitabine and cisplatin in patients with carcinoma of unknown primary site. Medical Oncology , vol.28, no.2 , 591-596.

Isik, M., Seker, M. M., Odabas, H., Kos, F. T., Uncu, D., & ZENGİN, N., (2011). Gemcitabine and cisplatin in patients with carcinoma of unknown primary site. Medical Oncology , vol.28, no.2, 591-596.

Isik, Metin Et Al. "Gemcitabine and cisplatin in patients with carcinoma of unknown primary site," Medical Oncology , vol.28, no.2, 591-596, 2011

Isik, Metin Et Al. "Gemcitabine and cisplatin in patients with carcinoma of unknown primary site." Medical Oncology , vol.28, no.2, pp.591-596, 2011

Isik, M. Et Al. (2011) . "Gemcitabine and cisplatin in patients with carcinoma of unknown primary site." Medical Oncology , vol.28, no.2, pp.591-596.

@article{article, author={Metin Isik Et Al. }, title={Gemcitabine and cisplatin in patients with carcinoma of unknown primary site}, journal={Medical Oncology}, year=2011, pages={591-596} }